2023 ASCO Review

Attending the American Society of Clinical Oncology (ASCO) Annual Meeting allows clinical staff the opportunity to review the latest research and gain valuable insights into emerging treatments and advancements in oncology. However, it is not always possible for individuals to attend. USMIRC had several members present on topics relating to multiple myeloma and other plasma cellular disorders. To ensure that innovative research and emerging treatments are readily available, Dr. Hamsa Hashmi provides a summary of the key takeaways from the event: 2023 ASCO Review .